Skip to content
OpenCapital
Get started

Zentalis Pharmaceuticals, Inc. ZNTL Q3 2025 earnings

Reported November 10, 2025 · Before market open

EPS-$0.37Beat by $0.12
EPS estimate-$0.49

Next report

Aug 5, 2026 (In 1 week)
EPS estimate-$0.45

Versus estimates

Revenue

Q4 2024$26.9M

Diluted EPS

Q1 2026-$0.50Miss by $0.01Q4 2025-$0.49Miss by $0.08
Q3 2025-$0.37Beat by $0.12
Q2 2025-$0.37Beat by $0.19Q1 2025-$0.67In lineQ4 2024-$0.66Beat by $0.09

Ask the moment Zentalis Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Zentalis Pharmaceuticals, Inc. report Q3 2025 earnings?
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Zentalis Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
Zentalis Pharmaceuticals, Inc. reported eps of $-0.37 for Q3 2025.
Did Zentalis Pharmaceuticals, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.49 by $0.12.
How did Zentalis Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 33.9% from $-0.56.
Where can I find Zentalis Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001725160-25-000159) and the 10-Q periodic report (0001725160-25-000161) directly on SEC EDGAR. The filing index links above go to sec.gov.